SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing significant community polarization, as long-term holders continue to emphasize long-term accumulation despite persistent price volatility and skepticism from traders questioning the lack of immediate upward momentum. The conversation centers on technical chart patterns and shifting macro indicators, with retail participants debating whether current levels represent a strategic entry point or a continuation of a downward trend.

CVR Energy, Inc. is a holding company. The firm engages in the petroleum refining and marketing business. It operates through the following segments: Petroleum, Renewables and Nitrogen Fertilizer. The Petroleum segment refines and markets high value transportation fuels. The Renewables segment includes the operations of the renewable diesel unit. The Nitrogen Fertilizer segment markets nitrogen fertilizers primarily in the form of UAN and ammonia. The company was founded in September 1906 and is headquartered in Sugar Land, TX.

CVR Energy Inc

CVR Energy is trending as investors weigh significant operational setbacks, including recent refinery fires and power outages, against the potential for a rebound driven by high-profile insider accumulation from Carl Icahn. The community is actively debating the company's dividend sustainability and its long-term strategic value in a volatile energy market, with many focused on whether current share prices present an overlooked opportunity or a warning sign.

Dogelon Mars

Dogelon Mars continues to capture attention as a speculative meme coin, with community sentiment split between frustration over stagnant price action and persistent optimism fueled by hopes for future burns, exchange listings, and ecosystem developments. Investors are actively debating the token's long-term utility versus its status as a high-risk asset, frequently comparing its performance to other major meme coins and major market leaders.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is currently capturing significant attention as investors actively debate its role as a leading meme coin and its potential for recovery following recent price volatility. While some community members are advocating for patient accumulation and long-term holding based on historical performance, others remain skeptical, engaging in heated discussions about the broader risks associated with meme coin cycles and competitive alternatives.

WorldFinancial

World Liberty Financial is experiencing intense market volatility and polarizing community debate following reports of a congressional probe into its foreign investment deals. While skeptics point to the investigation and historical price slides as evidence of a potential scam, bullish investors remain focused on upcoming product milestones and institutional interest as catalysts for a potential rebound.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

Binance's BNB is experiencing downward pressure following a double correction from its October peak, with the community actively debating whether current price levels are a trap or a solid accumulation zone. Investors are closely monitoring institutional movements and ongoing regulatory developments, including potential settlement news and the exchange's shifting security fund strategies, as sentiment remains polarized between long-term utility believers and those skeptical of market manipulation.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Toronto, Canada.

Bank of Montreal - MicroSectors Gold Miners -3X Inverse Leveraged ETNs

GDXD is capturing significant trader attention as a high-volatility play for those seeking to hedge or speculate against the relentless upward momentum in precious metals. The community is actively debating the timing of a potential gold correction, with many traders using it as a tactical tool to capitalize on daily swings while others warn of the risks associated with long-term decay in leveraged inverse ETFs.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

Ideaya Biosciences is trending as investors monitor the company's progress toward the highly anticipated Phase 2/3 PFS readout for darovasertib in metastatic uveal melanoma, with the community actively debating whether current low-volume price action reflects institutional accumulation or pre-readout anxiety. While analysts maintain strong conviction in the stock's potential as a future commercial-stage biotech, participants are closely tracking ongoing clinical execution and the broader regulatory outlook for the company's precision medicine oncology pipeline.

Tencent Holdings Ltd. provides value-added services, online advertising services, and fintech and business services. It operates through the following segments: Value-Added Services, FinTech and Business Services, Online Advertising, and Others. The Value-Added Services segment is involved in online and mobile games, community value-added services, and applications across various Internet and mobile platforms. The FinTech and Business Services segment offers fintech and cloud services, which include commissions from payment, wealth management and other services. The Online Advertising segment refers to the display based and performance-based advertisements. The Other segment is composed of trademark licensing, software development services, software sales, and other services. The company was founded by Yi Dan Chen, Hua Teng Ma, Chen Ye Xu, Li Qing Zeng, and Zhi Dong Zhang on November 11, 1998, and is headquartered in Shenzhen, China.

Tencent Holdings Ltd. - ADR

Tencent is trending as investors digest the integration of DeepSeek's AI models into the WeChat ecosystem and recent announcements regarding expanded robotaxi access through its mobility platform. The community remains focused on Tencent's defensive strength, often comparing its robust operating margins and AI-driven growth to broader Chinese tech peers while actively debating the impact of geopolitical labels and long-term monetization strategies.

What is Tron? Tron's mission is to build a truly decentralized internet and aims to be the largest blockchain-based operating system in the world, known as the TRON protocol. The TRON protocol will offer high scalability, high availability, and high throughput computing to serve decentralized applications via smart contracts. Ethereum EVM-based smart contracts will be compatible and deployable on the TRON network as such Solidity developers do not have to rewrite their applications.  Why Tron? Since TRON protocol does not rely on proof of work or mining, instead governed by nodes located around the world, it is decentralized while providing high throughput for transactions on the blockchain. This is suitable for dapps that require high speed transactions especially games. There are a number of tokens already issued on the TRON network and the decentralized exchanges TRX.market has launched.  On July 24th 2018, TRON acquired BitTorrent, one of the largest P2P file sharing protocol. As a result of the acquisition, BitTorrent Token (BTT) was launched as the cryptocurrency to power the economics on the BitTorrent network. The Token will be used to inceltivize file sharing and storage within the network.

Tron

Tron is generating significant community interest driven by its expanding role in global stablecoin transfers and recent strategic cloud partnerships. Investors remain bullish on its long-term network growth, while ongoing discussions focus on its resilience and potential for broader institutional adoption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharmaceutical Stocks Worth Watching - March 22nd

Abbott Laboratories, AbbVie, and Eli Lilly and Company are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies that research, develop, manufacture, and sell prescription drugs and related medical products, givi...

Promising Medical Stocks To Research - March 22nd

UnitedHealth Group, Abbott Laboratories, and AbbVie are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies that develop, manufacture, or provide products and services for the healthcare and medical industrie...

Wealth Enhancement Advisory Services LLC Purchases 134,139 Shares of Abbott Laboratories $ABT

Wealth Enhancement Advisory Services LLC grew its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 9.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,545,958 shares of the healthcare product maker...

Tealwood Asset Management Inc. Has $1.33 Million Holdings in Abbott Laboratories $ABT

Tealwood Asset Management Inc. decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 62.1% in the 4th quarter, according to the company in its most recent 13F filing...

Tealwood Asset Management Inc. Sells 17,462 Shares of Abbott Laboratories $ABT

Tealwood Asset Management Inc. trimmed its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 62.1% in the 4th quarter, according to its most recent disclosure with the SEC. The...

New England Research & Management Inc. Acquires 13,240 Shares of Abbott Laboratories $ABT

New England Research & Management Inc. increased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 128.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 23,574 shares of the healthcare product maker's...

Cyndeo Wealth Partners LLC Decreases Stock Position in Abbott Laboratories $ABT

Cyndeo Wealth Partners LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 8.8% in the fourth quarter, according to the company in its most recent 13F filing with...

Top Pharmaceutical Stocks To Research - March 21st

Abbott Laboratories, AbbVie, Eli Lilly and Company, Bristol Myers Squibb, and Gilead Sciences are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool...

Medical Stocks To Watch Today - March 21st

UnitedHealth Group, Abbott Laboratories, AbbVie, Eli Lilly and Company, and Merck & Co., Inc. are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks...

St. Louis Financial Planners Asset Management LLC Purchases New Position in Abbott Laboratories $ABT

St. Louis Financial Planners Asset Management LLC acquired a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the 4th quarter, according to the company in its most recent...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Current Price	$105.46
Prev Close	$107.19
Open	$107.04
Dividend Yield	1.92%
50-Day Moving Average	$113.11
Beta	0.27
Avg. Volume	9.88M
PE Ratio	28.37

52-Week High	$139.06
52-Week Low	$105.27
Market Capitalization	$183.26B
EPS (Annual)	$3.72
Price to Book	3.51
Revenue Per Employee	$385,460.87

ABT
Abbott Laboratories

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABT News

ABTAbbott Laboratories